Back to Journals

Integrated Blood Pressure Control

ISSN: 1178-7104

Dr Steven Atlas

Dr Atlas

Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Steven Atlas MD is an associate professor of medicine at the Mount Sinai School of Medicine (New York, NY) and chief of the Cardiology/Hypertension/Endocrinology Practice at the James J. Peters VA Medical Center (Bronx, New York), where he also directs the Hypertension Research Laboratory. He earned his medical degree from the Johns Hopkins University School of Medicine, followed by postgraduate training in medicine at the New York Hospital-Cornell Medical Center, and research training in clinical and biochemical pharmacology at the National Institutes of Health. After returning to Cornell for additional clinical training in hypertension and establishing a research program, he spent the next 17 years as a member of the Cornell faculty in the practice and teaching of cardiovascular medicine as well as in both clinical and basic biomedical research, before moving to Mount Sinai in 1994. 

Dr. Atlas is author of more than 200 publications concerning his clinical and investigative work. His research has focused on the renin-angiotensin system and the natriuretic peptide hormone family. He was one of the first investigators to study the ACE inhibitors, participating in the earliest clinical trials of captopril and subsequent agents. He has also published widely in the area of renin and prorenin biochemistry, and was one of the first investigators to isolate and characterize the atrial natriuretic peptide. Recent work has focused on the regulation of cardiac expression of angiotensin II and the natriuretic peptides, and he also remains active in clinical studies, including participation in major multicenter trials involving angiotensin receptor blockers, vasopeptidase inhibitors and, most recently, direct renin inhibitors.

Dr. Atlas has been an invited lecturer at medical and scientific meetings throughout the United States, Europe, Russia, and Japan. He reviews regularly for numerous medical journals and has been a member of several editorial boards and national research review committees (NIH, AHA and the VA). He is fellow of the council for High Blood Pressure Research and of the American Heart Association, and is a member of several other medical societies, including the American Society of Clinical Investigation, the Endocrine Society, and the American Society of Hypertension, where he is currently president of the eastern regional chapter.

Professor Turgay Celik

Professor Celik

Department of Cardiology, Wake Forest University, Winston-Salem, NC, USA

Turgay Celik is working as Senior Researcher at Wake Forest University nowadays. Dr. Celik earned his medical degree from Gulhane Military Medical Academy. He completed his residency at Cardiology Department of Gulhane Military Medical Faculty, Ankara, Turkey. He proudly served 25 years as an physician and academician for Turkish Armed Forces. His main research interests include arterial hypertension, interventional cardiology, acute cardiac care, dyslipidemia and heart failure.

Dr. Celik has authored more than 450 publications (h index=41) concerning his clinical and investigative work. His research has focused mainly on arterial hypertension, clinical cardiology, cardiac imaging, endothelial dysfunction, coronary artery disease, heart failure and interventional cardiology. His clinical study analyzing Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients has to this point received more than 345 citations. Dr. Celik has served as referee for a number of highly prestigious cardiovascular journals.

Dr Konstantinos Tziomalos

Dr Tziomalos

Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Konstantinos Tziomalos is Assistant Professor of Internal Medicine at the First Propedeutic Department of Internal Medicine of the Medical School, Aristotle University of Thessaloniki, in AHEPA Hospital, Thessaloniki, Greece. He completed his residency at the Second Propedeutic Department of Internal Medicine of the Medical School, Aristotle University of Thessaloniki, in Hippokration Hospital, Thessaloniki, Greece. He then served as a clinical research fellow at the Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free Campus, University College London Medical School, University College London, UK and as a post-doctorate research fellow at the Stem Cell Institute and Cardiovascular Research Laboratory, Division of Cardiology, Miller School of Medicine, University of Miami, USA.

His research interests include dyslipidemia, stroke and cardiovascular disease prevention. He has authored more than 300 peer-reviewed scientific articles, which have received more than 6000 citations.

Editorial Board

Abdel A. Abdel-Rahman, Professor, Department of Pharmacology and Toxicology, The Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA

Prof. Mansour M. Al Nozha, Professor of Medicine & Cardiology, Taibah University, Saudi Arabia.

Noori S. Al-Waili, Chairman and Consultant, Internist and Nephrologist, New York Medical Care for Nephrology and Hypertension Queens, New York, USA

Hayden B. Bosworth, Deputy Director, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; Professor and Vice Chair for Education, Department of Population Health Sciences; Research Professor, Department of Medicine, Division of General Internal Medicine, Department of Psychiatry and Behavioral Sciences, School of Nursing, Duke University Medical Center, NC, USA

Genc Burazeri, Epidemiology and Social Medicine Unit, Department of Public Health, Faculty of Medicine, University of Tirana, Albania

Vito M. Campese, Professor Emeritus of Medicine, Keck School of Medicine of USC, USA.

Mario Carvi Nievas, Neurosurgeon, Head consultant, Department of Neurosurgery, Hufeland Kliniken Mühlhausen, Germany.

Maureen Covelli, College of Nursing, University of Central Florida, FL, USA

Daniel Duprez,MD, PhD, Donald and Patricia Garofalo Chair in Preventive Cardiology, Professor of Medicine/Cardiology, Director of the Lipid Clinic, Director of the Rasmussen Center for Cardiovascular Disease Prevention, Professor Epidemiology and Community Health (School of Public Health), Cardiovascular Division, University of Minnesota, MN, USA.

Pedro A. Jose, MD, PhD, Professor of Medicine and Pharmacology/Physiology, Division of Renal Diseases & Hypertension, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA 20052

Helmy Siragy, Professor and Distinguished Chair of Excellence in Medical Education, Hypertension Centre, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA

Kerry Stewart, Professor of Medicine, Director, Clinical and Research Exercise Physiology, John Hopkins University School of Medicine, MD, USA.

Donna Wang, Distinguished Professor, Chief, Division of Nanomedicine and Molecular Intervention, Michigan State University, East Lansing, Michigan, USA